IE
TDAC

Israel Englander’s Translational Development Acquisition Corp TDAC Stock Holding History

Israel Englander’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-150,000
Closed -$1.59M – 6528
2026
Q1 		$1.59M Hold
150,000
– – ﹤0.01% 4071
2025
Q4 		$1.57M Hold
150,000
– – ﹤0.01% 4147
2025
Q3 		$1.55M Hold
150,000
– – ﹤0.01% 4267
2025
Q2 		$1.54M Buy
+150,000
New +$1.52M ﹤0.01% 4100

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Israel Englander's TDAC Position: Q2 2026 in Review

Israel Englander sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 150,000 shares — an estimated $1.59M sold.

Israel Englander first reported a position in TDAC in Q2 2025 and held it in 4 quarters. The position peaked at $1.59M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Israel Englander reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 150,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1.59M.
  • Israel Englander first reported a position in Translational Development Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • Israel Englander's Translational Development Acquisition Corp position peaked at $1.59M in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.